In Brief: Chiron/Genelabs
This article was originally published in The Gray Sheet
Executive Summary
Chiron/Genelabs: Firms finalize agreement under which Chiron and its partner, Johnson & Johnson subsidiary Ortho, gain rights to manufacture and market products based on Genelabs Technologies' hepatitis G virus in exchange for an investment worth up to $24 mil. A proposed agreement was announced in March ("The Gray Sheet" March 13, p. 16)...